Nathan Hardy

2023

In 2023, Nathan Hardy earned a total compensation of $1.2M as Executive Vice President, Chief Financial Officer at Sana Biotechnology.

Compensation breakdown

Non-Equity Incentive Plan$180,123
Option Awards$501,923
Salary$468,921
Stock Awards$30,800
Other$4,000
Total$1,185,767

Hardy received $501.9K in option awards, accounting for 42% of the total pay in 2023.

Hardy also received $180.1K in non-equity incentive plan, $468.9K in salary, $30.8K in stock awards and $4K in other compensation.

Rankings

In 2023, Nathan Hardy's compensation ranked 1,014th out of 2,918 executives tracked by ExecPay. In other words, Hardy earned more than 65.3% of executives.

ClassificationRankingPercentile
All
1,014
out of 2,918
65th
Division
Manufacturing
608
out of 1,608
62nd
Major group
Chemicals And Allied Products
418
out of 901
54th
Industry group
Drugs
407
out of 864
53rd
Industry
Biological Products, Except Diagnostic Substances
121
out of 211
43rd
Source: SEC filing on April 26, 2024.

Hardy's colleagues

We found two more compensation records of executives who worked with Nathan Hardy at Sana Biotechnology in 2023.

2023

Douglas Williams

Sana Biotechnology

Former Executive Vice President and President, Research and Development

2023

Steven Harr

Sana Biotechnology

Chief Executive Officer

News

You may also like